Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Omnicell, Inc.

OMCLNASDAQ
Healthcare
Medical - Healthcare Information Services
$39.56
$-0.70(-1.74%)
U.S. Market opens in 16h 16m

Omnicell, Inc. (OMCL) Stock Overview

Explore Omnicell, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio881.53
EPS (TTM)$0.04
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$30.54
3 Months$24.00
1 Year Target$32.49

OMCL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Omnicell, Inc. (OMCL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 881.53 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.74%
5-Day Change
6.46%
1-Month Change
-21.35%
3-Month Change
9.89%
6-Month Change
17.67%
Year-to-Date (YTD) Change
-12.36%
1-Year Change
-0.68%
3-Year Change
-25.79%
5-Year Change
-69.58%
All-Time (Max) Change
351.60%

Contact Information

650 251 6100
590 East Middlefield Road, Mountain View, CA, 94043

Company Facts

36,200 Employees
IPO DateAug 9, 2001
CountryUS
Actively Trading

Frequently Asked Questions